M. Seidensticker Et Al. , "Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort," CURRENT ONCOLOGY , vol.29, no.2, pp.565-577, 2022
Seidensticker, M. Et Al. 2022. Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort. CURRENT ONCOLOGY , vol.29, no.2 , 565-577.
Seidensticker, M., Steffen, I. G., Bargellini, I., Berg, T., Benito, A., Gebauer, B., ... Iezzi, R.(2022). Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort. CURRENT ONCOLOGY , vol.29, no.2, 565-577.
Seidensticker, Max Et Al. "Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort," CURRENT ONCOLOGY , vol.29, no.2, 565-577, 2022
Seidensticker, Max Et Al. "Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort." CURRENT ONCOLOGY , vol.29, no.2, pp.565-577, 2022
Seidensticker, M. Et Al. (2022) . "Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort." CURRENT ONCOLOGY , vol.29, no.2, pp.565-577.
@article{article, author={Max Seidensticker Et Al. }, title={Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort}, journal={CURRENT ONCOLOGY}, year=2022, pages={565-577} }